SEC Form 4 · accession 0001209191-18-008609
aTYR PHARMA INC · LIFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ashraf Amanullah
Officer — See Remarks
Period of report
Feb 6, 2018
Accepted (ET)
Feb 8, 2018 · 8:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001339970
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 7, 2018 | M | 3,334 | $0.00 | A | 3,334 | D | |
| Common Stock | Feb 8, 2018 | S | 1,402 | $3.40 | D | 1,932 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $3.30 | Feb 6, 2018 | A | 100,000 | A | — | Feb 6, 2028 | Common Stock | 100,000 | 100,000 | D |
| Restricted Stock UnitsF4 | $0.00 | Feb 7, 2018 | M | 3,334 | D | — | — | Common Stock | 3,334 | 6,666 | D |
Explanation of responses
- F1Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 7, 2017.
- F2Sale made by the Reporting Person in compliance with the provisions of Rule 10b5-1 to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on February 7, 2017.
- F3The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 6, 2018, such that this option will be fully exercisable on February 6, 2022. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.
- F4The RSU grant vests as to one-third (1/3) of the total number of units on each one year anniversary of the grant commencing on February 7, 2018.
Remarks
Senior Vice President, Biologics Development and Manufacturing